Title:
A randomized Phase III study to compare arsenic trioxide (ATO) combined to ATRA and idarabucin versus standard ATRA and anthracycLine-based chemotherapy (AIDA regimen) for patients with newLy diagnosed, high-risk acute prOmyelocytic leukemia - APOLLO-Study
Phase:
III
Contact:
Diana Six / Study Nurse
Email-Address:
Diana.Six@med.uni-heidelberg.de
Clinical Investigator:
Prof. Dr. Alwin Krämer
Registration:
Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe
NCT02688140
EudraCT-Number:
(siehe EU klinisches Studienregister)
2015-001151-68